A Tale of Two Spinal Cord Injury Patients

Shenzhen, China –- June 16th, 2006 — Shenzhen Beike Biotechnology Co., Ltd has announced the successful treatment of two spinal cord injury patients with different methods for treatment – one…

Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis

Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis

New Published Research Finds Improvement in Liver Function in Patient with Primary Biliary Cirrhosis SHENZHEN, China, July 3, 2012 /PRNewswire-Asia/ — A study conducted by Beike Biotechnology Company (http://www.beikebiotech.com) in…

Beike Biotechnology Receives International Recognition for Quality Control Processes

Leading Chinese Stem Cell Therapy Provider Awarded Three ISO9001 Certifications for Stem Cell Technology Quality Management System TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the…

New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients’ Functionality and Quality of Life

New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients’ Functionality and Quality of Life

In an Open Label Treatment Study 30 Patients with the Neurodegenerative Disorder Hereditary Ataxia Were Treated with Stem Cells Provided by Beike Biotechnology SHENZHEN, China and SAN DIEGO, Calif., Sept….

First Cerebral Palsy treatment using two types of stem cells

First Cerebral Palsy treatment using two types of stem cells

Just in time for Cerebral Palsy (CP) awareness month, Europe’s ESPERITE group is championing the first clinical trial to utilize two types of stem cells for the treatment of Cerebral…

Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.

SHENZHEN, China, Nov. 4 /PRNewswire-Asia/ — Shenzhen Beike Biotechnology Co. Ltd. (http://www.beikebiotech.com ), China’s leading stem cell research and regenerative medicine company, announced that it has entered into an agreement…


1 2 8 9